YD Bio Ltd Logo

YD Bio Ltd

Developing blood-based cancer detection and regenerative therapies for biopharma partners.

YDES | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
955 WEST JOHN CARPENTER FREEWAY, 75039 IRVING
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

YD Bio Ltd. is a biotechnology company focused on developing advanced detection and therapeutic technologies. The company specializes in early, blood-based cancer detection utilizing proprietary DNA methylation-based technology. In parallel, its therapeutic division is advancing a pipeline of next-generation regenerative solutions, including stem cell- and exosome-based therapies, with a notable focus on ophthalmology. YD Bio's business model centers on forming partnerships with biopharmaceutical firms to transform its innovative technologies into commercially available diagnostics and treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all YD Bio Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for YD Bio Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for YD Bio Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

curacle co., ltd. Logo
Developing drugs for intractable diseases like diabetes caused by vascular damage and aging.
South Korea
365270
Curanex Pharmaceuticals Inc Logo
Developing botanical drugs for inflammatory diseases, diabetes, and COVID-19.
United States of America
CURX
Curevac Logo
Pioneering mRNA technology to create vaccines and therapies for infectious diseases, cancer, and more.
Germany
CVAC
CureVac N.V. Logo
Pioneering mRNA technology for prophylactic vaccines and novel cancer immunotherapies.
United States of America
CVAC
CURIS INC Logo
Biotech developing innovative cancer therapeutics for hematologic malignancies.
United States of America
CRIS
Curocell Inc. Logo
Biotech developing enhanced CAR-T therapies for cancer using its OVIS™ platform.
South Korea
372320
CYBIN INC. Logo
A clinical-stage firm engineering novel psychedelic drugs for depression and anxiety.
United States of America
CYBN
Cyclerion Therapeutics, Inc. Logo
Developing personalized therapy for TRD with a biofeedback device and anesthetics.
United States of America
CYCN
CYTOKINETICS INC Logo
Late-stage biopharma developing muscle-modulating drugs for heart and neuromuscular diseases.
United States of America
CYTK

Talk to a Data Expert

Have a question? We'll get back to you promptly.